Pharma Journalist 8962 posts 0 comments

PeptiDream announced that it has entered into a multi-program collaborative research agreement with Osaka-based Shionogi & Co., Ltd for the discovery and development of a series of…
Read More...

Philogen announced through its wholly-owned Swiss subsidiary, Philochem AG, a collaboration agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson…
Read More...

Incyte Corporation announced that the first patient has been treated in GRAVITAS-309, a pivotal Phase 3 trial for the first-line treatment of patients with chronic graft-versus-host…
Read More...

Alvotech announced that it has successfully raised US$300 million through a private bond offering. Net proceeds from the capital raised will be used to fuel continued growth, refinance…
Read More...

Ferring Pharmaceuticals and Karolinska Institutet announced a five-year extension of their collaboration to explore the potential of the human microbiome in reproductive medicine and…
Read More...

Gamida Cell Ltd. and Be The Match BioTherapies, a subsidiary of the National Marrow Donor Program/Be The Match offering integrated platforms and software to manage the collection and…
Read More...

SMi reports: Associate Director at ProQR is set to present at the 10th Annual RNA Therapeutics Conference, taking place on 20th – 21st February 2019 in London. Undoubtedly, the field…
Read More...

GlaxoSmithKline plc announced that it has successfully completed the acquisition of TESARO, Inc. an oncology-focused company based in Waltham, Massachusetts, for an aggregate cash…
Read More...

Vertex Pharmaceuticals (Europe) Limited announced that the European Commission has granted approval of the label extension for ORKAMBI (lumacaftor/ivacaftor) for the treatment of…
Read More...

Alnylam Pharmaceuticals and Medison Pharma announced an exclusive agreement to commercialize ONPATTRO, the first-ever commercialized RNAi therapeutic, as well as other investigational…
Read More...